Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

6.8K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.8K
Response Surface Methodology01:16

Response Surface Methodology

580
Response Surface Methodology (RSM) is a collection of statistical and mathematical techniques used to develop, improve, and optimize processes. It is particularly valuable when many input variables or factors potentially influence a response variable.
The process of RSM involves several key steps:
580

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visual Evoked Potentials as a Biomarker for Visual Hallucination Pathway Integrity in Late-Stage Alzheimer's Disease.

Clinical EEG and neuroscience·2025
Same journal

Readability of informed consent forms from ClinicalTrials.gov in ketamine clinical trials for mental health conditions: a cross-sectional analysis.

Therapeutic advances in psychopharmacology·2026
Same journal

Patient-centred education for ketamine and esketamine therapies in mood disorders.

Therapeutic advances in psychopharmacology·2026
Same journal

Benzodiazepine receptor agonist deprescribing principles for long-term use and dependence: modified Delphi recommendations from a multi-disciplinary expert panel.

Therapeutic advances in psychopharmacology·2026
Same journal

Cariprazine augmentation for negative symptoms of schizophrenia: a prospective analysis and literature review.

Therapeutic advances in psychopharmacology·2026
Same journal

Adjunctive aripiprazole for amisulpride-induced hyperprolactinemia: a preliminary retrospective study showing no reversing effect.

Therapeutic advances in psychopharmacology·2026
Same journal

Early suicidal ideation change and suicidality-associated emergency department utilization after ketamine or esketamine treatment in treatment-resistant depression.

Therapeutic advances in psychopharmacology·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Predicting rTMS treatment response in schizophrenia using interpretable machine learning: a SHAP-based analysis.

Jingyuan Lin1

  • 1Department of Neurology, Fujian Provincial Geriatric Hospital, Fuzhou, Fujian 350003, China.

Therapeutic Advances in Psychopharmacology
|December 19, 2025
PubMed
Summary
This summary is machine-generated.

Machine learning models can predict individual responses to repetitive transcranial magnetic stimulation (rTMS) for schizophrenia. Key predictors include baseline functioning and symptom severity, aiding personalized treatment strategies.

Keywords:
SHAPclinical predictorsmachine learningrTMSschizophreniatreatment response

More Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.5K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.1K

Related Experiment Videos

Last Updated: Jan 8, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.5K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.1K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Artificial Intelligence

Background:

  • Individual responses to repetitive transcranial magnetic stimulation (rTMS) in schizophrenia are highly variable.
  • There is a lack of predictive clinical tools to guide rTMS treatment decisions.

Purpose of the Study:

  • To develop and interpret machine learning models for predicting individual rTMS treatment response in schizophrenia patients.
  • To identify baseline clinical features that predict response to rTMS therapy.

Main Methods:

  • Retrospective analysis of 156 schizophrenia patients' data, including Positive and Negative Syndrome Scale (PANSS) and Global Assessment of Functioning (GAF) scores.
  • Training and evaluating multiple machine learning models (Random Forest, XGBoost, SVM, logistic regression) using demographic and clinical features.
  • Utilizing cross-validation, a temporal hold-out set, and Shapley Additive Explanations (SHAP) for model interpretation.

Main Results:

  • The Random Forest model demonstrated the highest predictive performance with a cross-validated AUC of 0.84 and a temporal hold-out AUC of 0.70.
  • Moderate baseline GAF scores and higher PANSS scores were identified as significant predictors of rTMS response.
  • Model performance plateaued around 100 cases, suggesting sufficient data for reliable predictions.

Conclusions:

  • Interpretable machine learning models can identify baseline features associated with individual rTMS response in schizophrenia.
  • These findings support the potential for personalized interventions to optimize rTMS therapy.
  • External validation is necessary to confirm the generalizability of these predictive models.